tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joel Beatty, 68 are a HOLD (15.96%), 5 are a SELL (1.17%), 353 are a BUY (82.86%).
Analyst Joel Beatty, currently employed at BAIRD, carries an average stock price target met ratio of 60.46% that have a potential upside of 46.49% achieved within 361 days.
Joel Beatty’s has documented 833 price targets and ratings displayed on 80 stocks. The coverage is on Healthcare, Consumer Defensive, Energy, Industrials sectors.
Most recent stock forecast was given on ALKS, Alkermes Plc at 22-Sep-2026.
Analyst best performing recommendations are on NK (NANTKWEST).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES) at 3/3/2023. The price target of $11 was fulfilled within 3 days with a profit of $4.57 (71.07%) receiving and performance score of 236.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-May-2025
$369
$149.28 (67.94%)
$375
Buy Since 12-Feb-2021
$455
$235.28 (107.08%)
$455
12 days ago
(21-Sep-2026)
23/41 (56.1%)
$210.68 (86.23%)
688
Hold Since 08-Sep-2026
$260
$40.28 (18.33%)
$330
25 days ago
(08-Sep-2026)
2/2 (100%)
$-0.1 (-0.04%)
8
Buy Since 21-Mar-2025
$318
$98.28 (44.73%)
$583
1 months 14 days ago
(19-Aug-2026)
34/36 (94.44%)
$75.39 (31.07%)
263
Hold Since 20-Oct-2025
$256
$36.28 (16.51%)
$316
1 months 19 days ago
(14-Aug-2026)
2/6 (33.33%)
$27.35 (11.96%)
38
Which stock is Joel Beatty most bullish on?
Which stock is Joel Beatty most reserved on?
What Year was the first public recommendation made by Joel Beatty?
